Chemical process development of an active pharmaceutical ingredient (API) or drug substance and the pharmaceutical development of the final, formulated drug product from this API are frequently treated as independent activities in the overall process of developing a new drug. However, this independent approach can lead to challenges such as an API that is difficult to handle or requires additional processing before manufacturing the final formulation. An integrated approach to product development can serve to avoid common pitfalls and focus efforts to where real issues exist as a result of a mismatch between the API properties and the requirements placed upon the formulated product. This white paper covers API properties and their impact upon formulation, a smart approach to product development, and more. Download now to learn more.
Please check the highlighted fields and try again.
Please fill out the information below. If you are already registered, login and this information will be filled out for you.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.
Please enter the phone number you would like to be contacted at.